SCHEMBL23749766

SCHEMBL23749766

CC(C)(C)OC(=O)NCc1ccccc1-n1ccsc1=N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA5 P22460 1/20 0.42
▸ KDM4A O75164 1/20 0.40
▸ HDAC10 Q969S8 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ DRD2 P14416 5/20 0.39
▸ NAMPT P43490 1/20 0.39
▸ BRD9 Q9H8M2 1/20 0.38
▸ BAZ2B Q9UIF8 1/20 0.38
▸ BAZ2A Q9UIF9 1/20 0.38
▸ IDO1 P14902 1/20 0.37
▸ HPGD P15428 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ SETDB1 Q15047 1/20 0.36
▸ SIRT1 Q96EB6 1/20 0.36
▸ NQO2 P16083 1/20 0.35
▸ BCHE P06276 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30393091 1.00 KCNA5 (0.42) KCNA5KDM4AHDAC10HDAC6DRD2
SCHEMBL23727106 0.84 KCNA5 (0.39) KCNA5KDM4AHDAC10HDAC6DRD2
SCHEMBL23727105 0.84 KCNA5 (0.39) KCNA5KDM4AHDAC10HDAC6DRD2
SCHEMBL30130845 0.82 BCHE (0.40) HPGDLMNABCHE
SCHEMBL30130838 0.80 KCNA5 (0.37) KCNA5KDM4AHDAC10HDAC6DRD2
SCHEMBL23749868 0.77 GLS (0.45) KDM4ANAMPTBRD9BAZ2BBAZ2A
SCHEMBL30130815 0.77 GLS (0.45) KDM4ANAMPTBRD9BAZ2BBAZ2A
SCHEMBL25001926 0.77 KMT2A (0.43) DRD2HPGDLMNA
SCHEMBL8018113 0.76 KCNA5 (0.56) KCNA5KDM4AHDAC10HDAC6NAMPT
SCHEMBL30159605 0.76 KCNA5 (0.56) KCNA5KDM4AHDAC10HDAC6NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230137893-A1 PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS THE ROCKEFELLER UNIVERSITY (US) 2023-05-04 — — US disclosed
US-20230137893-A1 PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS THE ROCKEFELLER UNIVERSITY (US) 2023-05-04 — — US disclosed
WO-2021158936-A1 PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS THE ROCKEFELLER UNIVERSITY (US) 2021-08-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230137893-A1 PYRROLO[2,3-b]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS LATS2, LATS1, YAP1 KCNA5 3400/4885KDM4A 2180/4885HDAC10 1377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback